ArticleJournal of cellular and molecular medicine2026
Correction to "Sprouty2 Suppresses Progression and Correlates to Favourable Prognosis of Intrahepatic Cholangiocarcinoma via Antagonizing FGFR2 Signalling".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.